Market Minds Advisory
Biotin Ingredients Market

Biotin Ingredients Market: Biotin Ingredients Market. Feed Volumes, Supplement Demand, and Chinese Production Concentration Shape Global Supply.

Biotin, vitamin B7, sits between livestock feed volumes and beauty supplement demand, where Chinese production scale, purity specifications, and laboratory test interference warnings decide which suppliers hold premium contracts and which compete on price.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$0.9BMarket Size 2025
2036 FORECAST VALUE$1.7BBase Case , 2026 to 2036
CAGR 2026 TO 20365.8 %Bull 7.1% / Bear 4.5%
INCREMENTAL OPPORTUNITY$0.7BNet 10- year value creation
EXPANSION MULTIPLE1.76x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Biotin is a water-soluble B vitamin sold as a fine crystalline ingredient for animal feed, dietary supplements, food fortification, pharmaceuticals, and cosmetics. Feed absorbs most volume, while supplements and beauty products earn the highest prices. Chinese production scale and purity control shape supply. Brands reward consistency over novelty.
Cosmetic and Personal Care Grade Biotin grows fastest as hair, skin, and nail brands adopt higher-purity grades. East Asia holds the largest share, since Chinese plants make most of the world's biotin and Japanese and Korean brands buy beauty grades, while North America and Western Europe follow through supplement and premix demand. Purity sets price. Feed volume sets scale. Buyers audit suppliers yearly. Contracts decide renewal.
Competition is concentrated, with a Dutch nutrition science group, two Chinese vitamin producers, a Chinese vitamin and nutrition group, and a global chemicals major leading on synthesis skill, purity, and premix reach, while smaller Chinese plants supply lower-cost feed grade. Environmental rules govern Chinese output, and EU and US supplement rules govern labelling. Scale gates feed accounts. Purity gates premium accounts. Buyers test every lot, and one failed lot can cost a contract.
Market Definition
The market covers global sales of biotin as an ingredient, valued at supplier level, including feed grade biotin, dietary supplement grade biotin, pharmaceutical and clinical grade biotin, cosmetic and personal care grade biotin, and food fortification grade biotin, sold in crystalline, granulated, and premix forms. The scope excludes finished supplements, finished cosmetics, multi-vitamin premixes sold as blended products, and other B vitamins.
Base Year Value
$0.9B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
5.8% base case. Bull 7.1%. Bear 4.5%.
Fastest Growth Segment
Cosmetic and Personal Care Grade Biotin: 8.9% CAGR
Fastest Growth Country
India: 8.2% CAGR
Fastest Growth Region
South Asia and Pacific: 7.8% CAGR
Largest Region
East Asia: 39% of 2025 global value
Market Leaders
DSM-Firmenich, Zhejiang Medicine, Zhejiang NHU, Kingdomway Group, Fermenta Biotech. Source: MMA Analysis, company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Biotin Ingredients Market Forecast Scenarios

biotin-ingredients-market-size-forecast-scenario-1789850983962
Between 2020 and 2025, biotin demand grew as poultry and swine output expanded, hair, skin, and nail supplements spread across Asia and North America, and food fortification widened in emerging markets. Chinese energy rationing and freight swings disrupted supply, and prices spiked in 2021 before easing. Cosmetic and supplement grades grew faster than feed grade. Supply contracts decide renewal.
The base case rests on three commercial mechanisms. First, livestock output keeps growing in Asia and Latin America, which lifts feed biotin volumes. Second, beauty-from-within and hair care supplements keep adopting higher-purity grades. Third, suppliers add fermentation routes, purity upgrades, and premix services, which widen use and protect margin. Suppliers plan capacity, synthesis, and certification around all three. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season.
The bull case needs faster supplement growth in India and Southeast Asia and tighter Chinese output limits, which would lift prices. The bear case is new low-cost Chinese capacity combined with weak livestock margins, which would squeeze prices and delay investment. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.

Feed Volumes, Beauty Demand, and Chinese Production Scale Set Biotin Outcomes

Biotin supply starts with chemical synthesis from intermediates such as fumaric acid derivatives and sulfur compounds, a multi-step route that runs over many days in reactors under controlled temperature. Producers crystallise, filter, and dry the product, then test for purity, particle size, and residual solvents. A smaller fermentation route is emerging. Ingredient houses then sell crystalline and granulated grades to premix, supplement, food, and cosmetic buyers.
MARKET CONCENTRATION58% CR5Leading five suppliers hold a high combined share
TYPICAL FEED INCLUSION50-300 ug/kgUsual biotin dose in poultry and swine feed
SYNTHESIS COST SHARE52%Portion of goods cost taken by chemical synthesis and purification
CHINA PRODUCTION SHARE75%Portion of global biotin output made in Chinese plants
FEED APPLICATION SHARE58%Portion of biotin volume sold into animal feed premixes
BATCH CYCLE TIME10-14 daysTypical time from raw material to finished biotin lot
Purity, particle size, solubility, and stability decide value. Feed buyers set tight assay limits, and pharmaceutical and cosmetic grades earn premiums of 40% to 120% over feed grade. Large plants win on cost and yield, while specialists win on purity and certification. Suppliers with audited plants and clean traceability win, since global premix makers inspect closely. Audits repeat yearly. Sampling takes weeks.
Buyers judge biotin on assay, stability, and price. Premix makers want consistent potency at low cost, supplement brands want purity and clean labels, and cosmetic buyers want documentation. Price sensitivity is high in feed, since the dose is small but volumes are large, and moderate in beauty grades. Delivery slots matter as premix schedules run tight. Samples decide shortlists. Small importers feel every input swing.
"Biotin looks like a small vitamin, but its supply chain is one of the most concentrated in nutrition. A handful of plants, mostly in China, set the price for feed and supplements alike, so the buyer who ignores plant risk will pay for it in a single quarter."
Senior Analyst, Vitamins and Nutritional Ingredients Practice · MMA Biotin Ingredients Practice · September 2026

Market Trends

Hair, Skin, and Nail Supplements Lift Cosmetic Grade Biotin Demand

Beauty-from-within brands launch hair, skin, and nail gummies, powders, and tablets that use higher doses of biotin, and topical hair care brands add biotin to shampoos and serums. Cosmetic and Personal Care Grade Biotin grows about 8.9% a year, and beauty grades earn gross margins of 38% to 52% against 22% to 32% for feed grade. The trend needs documentation and purity data, and it rewards suppliers with certified plants and application support. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
Market Impact: poultry output grows 2-3% yearly

Fermentation-Based Biotin Routes Attract Investment From Major Producers

Producers test fermentation routes that promise lower solvent use and bio-based labels, and brands ask for sustainable and clean-label vitamin sources. Fermentation could cover 10% to 15% of supply by 2036, though yields remain below chemical synthesis. The trend needs strain work and scale-up capital of $20 million to $60 million per plant, and it rewards suppliers with fermentation skill, patents, and access to brands willing to pay premiums. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.
Market Impact: Asian supplements grow 8-10% yearly

Market Opportunities and Growth Drivers

Livestock Output Growth Sustains Feed Biotin Volumes

Poultry and swine output keeps rising in Asia, Latin America, and Africa as protein demand grows, and integrated producers add biotin to premixes to support hoof, feather, and skin health. Global poultry meat output grows about 2% to 3% a year, according to USDA and FAO records. The driver sustains steady demand for feed grade biotin and rewards suppliers with low cost, consistent potency, and reliable delivery to premix makers. Small importers feel every input swing. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
Market Impact: warnings cut high-dose sales 5-10%

Supplement Use in India and Southeast Asia Widens Buyers

Rising incomes, pharmacy expansion, and social media promotion bring hair, skin, and nail supplements to millions of new buyers in India, Indonesia, and Vietnam, and local makers import biotin through distributors. Asian supplement markets grow 8% to 10% a year. The driver sustains premium demand for dietary supplement grade biotin and rewards suppliers that offer small lots, sample speed, and documentation that supports local registration. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing.
Market Impact: single curbs lift prices 30-80%

Market Restraints and Challenges

Laboratory Test Interference Warnings Limit High-Dose Supplement Marketing

Regulators such as the FDA have warned that high-dose biotin can distort results of common blood tests, including thyroid and cardiac markers, and retailers and doctors now advise caution. The root cause is assay chemistry that uses biotin binding. Suppliers respond with lower-dose formats and label warnings, though warnings cut high-dose sales by 5% to 10% in some markets and delay new supplement launches in cautious channels. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season.
Market Impact: cosmetic grade grows 8.9% yearly

Chinese Production Concentration and Environmental Curbs Create Supply Risk

Chinese plants make about 75% of global biotin, and provincial authorities limit power and emissions during peak periods, which caused price spikes and shortages in 2021. The root cause is energy-intensive multi-step synthesis and solvent handling. Buyers respond with second sources and safety stock, though a single curb can lift prices by 30% to 80% within weeks and force premix makers to reformulate. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing. Technical reach compounds over time. Brands reward consistency over novelty.
Market Impact: fermentation reaches 10-15% of supply
3 additional market trends, 2 additional growth drivers, and 4 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

The global biotin ingredients market is segmented by end-use grade, which shows where purity, documentation, and application support create pricing power. Five segments cover feed grade, dietary supplement grade, pharmaceutical and clinical grade, cosmetic and personal care grade, and food fortification grade. Cosmetic and supplement grades grow fastest as beauty-from-within demand widens beyond established feed volumes.
biotin-ingredients-market-market-share-analysis-1789850984225

Cosmetic and Personal Care Grade Biotin

Cosmetic and Personal Care Grade Biotin is the fastest-growing segment at 8.9% a year, about 1.53 times the overall market rate, from a small base. Hair care and beauty brands want higher-purity, documented biotin for shampoos, serums, and gummies, and gross margins of 38% to 52% against 22% to 32% for feed grade support investment. Documentation and purity data are the main constraints. Suppliers with certified plants win. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing. Technical reach compounds over time.
CAGR 8.9%

Dietary Supplement Grade Biotin

Dietary Supplement Grade Biotin grows at 7.4% a year, because supplement makers launch hair, skin, and nail products and buyers accept gross margins of 34% to 46% for grades with clean documentation and consistent particle size. Laboratory test interference warnings and high-dose limits are the main constraints, since retailers and doctors urge caution. Suppliers with lower-dose formats and label support hold price better than followers. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing. Technical reach compounds over time.
CAGR 7.4%
Full segment breakdown across 5 segments available in the complete report.

Regional Architecture and Country Demand Map

East Asia holds the largest share because Chinese plants make roughly 75% of global biotin and Japanese and Korean brands buy beauty grades, so its share sits above the usual band. North America follows through supplements and Western Europe through premix houses. South Asia and Pacific grows fastest.

East Asia

East Asia holds 39% share, above its usual band, and leads because Chinese plants make roughly 75% of global biotin, so value at supplier level sits where synthesis and purification run, and Japanese and Korean brands add large beauty grade demand. Zhejiang Medicine, Zhejiang NHU, and Kingdomway Group sit in this region. Growth exceeds the global rate. Environmental curbs, energy cost, and price competition restrain margins, while purity and certification lift returns. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing.
Share: 39% | CAGR: 6.8% (2026 to 2036)

North America

North America holds 22% share, at the bottom of its band, because the United States hosts the largest supplement and premix markets outside Asia and buyers such as Balchem, Kemin, and large premix makers purchase biotin in volume from Chinese and European suppliers. FDA supplement rules and test interference warnings shape marketing. Growth runs below the global rate. Import cost, tariffs, and price competition restrain margins. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing.
Share: 22% | CAGR: 5.3% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
biotin-ingredients-market-country-cagr-analysis-1789850984569

Four Margin Routes for Biotin Suppliers

Margin in biotin comes from purity grades, secured production, premix services, and fermentation options rather than feed grade volume. The routes below apply to global vitamin producers, Chinese plants, and ingredient distributors, and each can start inside one planning cycle, with clear measures in gross margin points, cost per kilogram, and customer programmes served.

Moving Volume Into Cosmetic and Supplement Purity Grades

Beauty grades earn gross margins of 38% to 52% against 22% to 32% for feed grade, so suppliers that add purification lines, documentation, and certification to shift 10% of volume into cosmetic and supplement grades report gross margin gains of 3 to 6 points on the mix. Upgrades cost $3 million to $10 million per plant. Pilots with four brands confirm demand. Small importers feel every input swing. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season.
Market Impact: grade mix shift lifts gross margin by 3-6 points

Offering Low-Dose and Clean-Label Formats After Test Interference Warnings

Test interference warnings cut high-dose sales by 5% to 10% in cautious channels, so suppliers that offer low-dose blends, labelling guidance, and documentation win supplement programmes that competitors lose. Format development costs $0.5 million to $2 million. Suppliers should publish guidance, share regulatory summaries with brands, and support retailer requests to retain shelf position and protect repeat orders. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal.
Market Impact: low-dose formats recover 5-10% of lost supplement sales

Building Second-Source and Safety Stock Programmes for Premix Buyers

Chinese curbs can lift biotin prices by 30% to 80% within weeks, so suppliers that hold safety stock and dual-site production win premix contracts on reliability. Programmes cost $2 million to $6 million in working capital. Suppliers should offer supply guarantees, index-linked pricing, and quarterly forecasts to buyers, and should rank customers by margin and switching risk before allocating stock. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small importers feel every input swing.
Market Impact: safety stock programmes protect contracts through 30-80% price spikes

Piloting Fermentation Routes for Bio-Based Biotin Programmes

Fermentation could cover 10% to 15% of supply by 2036, and brands will pay premiums of 15% to 30% for bio-based labels, so suppliers that pilot strains, patents, and partnerships now can lock in early accounts. Pilots cost $5 million to $15 million. Suppliers should test with three brands, measure yield against chemical routes, and scale only where premiums cover capital. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales.
Market Impact: bio-based labels earn premiums of 15-30% over chemical biotin

Who Controls the Margin Pool

The global biotin ingredients market is highly concentrated, with a CR5 of 58%, and distributors, premix houses, and smaller Chinese plants sit outside the leading five. This assessment measures participants on estimated biotin production capacity, held constant across all players. DSM-Firmenich leads through purity, premix reach, and brand trust, while Zhejiang Medicine, Zhejiang NHU, Kingdomway Group, and Fermenta Biotech follow, with a clear gap between the leader and the challengers.
Competition runs on four dimensions today: production cost and yield, purity and certification, premix and application support, and supply security. Global houses win on purity and reach, while Chinese plants win on cost and scale. Imitators copy standard feed grades quickly, so premiums outside certified beauty and supplement grades erode within a season, and price competition appears in feed supply. Cost control separates leaders from followers.

Emerging pressure comes from Chinese producers moving into certified beauty grades, fermentation entrants offering bio-based labels, and regulators tightening supplement labelling. Rankings shift where a supplier adds low-cost capacity, wins a premix programme, or secures a bio-based brand. Chinese plants can move up quickly, since cost and scale can outweigh legacy brands. Clear specifications build buyer trust.
biotin-ingredients-market-company-positioning-matrix-1789850984871

Competitive Moat and Risk Dimensions

DSM-FIRMENICH

Moat: Purity, Premix Reach, Brand Trust

DSM-Firmenich, a Dutch and Swiss nutrition science group, supplies vitamins including biotin to feed, food, supplement, and pharmaceutical buyers and supports them with premix services and technical teams. Its purity standards, global plants, and application laboratories give it credibility with major brands, and its position supports multi-market supply contracts and bundled vitamin offers across premix and supplement programmes.
DSM-FIRMENICH

Risk: Chinese Cost Gap

DSM-Firmenich competes with Chinese plants that sell biotin at lower cost, and feed buyers switch on price. Rivals with lower cost can win volume programmes and pressure premium accounts. Small importers feel every input swing. Technical reach compounds over time. Brands reward consistency over novelty. Supply contracts decide renewal.
ZHEJIANG MEDICINE

Moat: Low-Cost Synthesis at Scale

Zhejiang Medicine, a Chinese pharmaceutical and vitamin producer, runs large biotin synthesis capacity and sells to global premix makers, supplement brands, and distributors. Its scale, integrated intermediates, and cost position give it reach in feed and supplement grades, and its position supports long supply agreements with global buyers who value volume, delivery, and competitive pricing.
ZHEJIANG MEDICINE

Risk: Environmental Curb Exposure

Zhejiang Medicine operates in regions where authorities limit power and emissions, and curbs can cut output and raise cost. Buyers hold second sources, and premium accounts require audit records. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales.

Players Tracked

Prominent Players

DSM-Firmenich
Zhejiang Medicine
Zhejiang NHU
Kingdomway Group
Fermenta Biotech

Other Key Players

BASF
Adisseo
Lonza
Kemin
Kerry Group
Prinova Group
Barentz
Brenntag
Univar Solutions
Azelis
CSPC Pharmaceutical
Vertellus
Jubilant Ingredients
Balchem
Nutreco

Recent Developments

JANUARY 2026

DSM-Firmenich Extends Cosmetic Grade Biotin Range With New Purity Documentation

DSM-Firmenich extended its cosmetic grade biotin range with new purity documentation, according to company communications. It is a product range extension, not an acquisition, and it tests whether documentation supports premium pricing. Sales volumes were not disclosed. Cost control separates leaders from followers. Clear specifications build buyer trust.
Signal: Suggests leading houses are using purity documentation to defend premiums as cheaper Chinese grades enter beauty channels.
FEBRUARY 2026

Zhejiang Medicine Announces Biotin Capacity Expansion at Existing Chinese Site

Zhejiang Medicine announced a biotin capacity expansion at an existing Chinese site, according to company communications. It is organic capacity expansion, not an acquisition, and it tests demand from premix and supplement customers. Investment values were not disclosed. Small importers feel every input swing. Technical reach compounds over time.
Signal: Confirms Chinese producers are steadily adding biotin capacity to serve rising feed and supplement demand from global buyers.
MARCH 2026

Kingdomway Group Introduces Low-Dose Biotin Blends for Supplement Brands

Kingdomway Group introduced low-dose biotin blends for supplement brands, supported by labelling guidance and documentation. It is a product launch, and it tests demand for lower-dose formats after test interference warnings. Sales volumes were not disclosed. Brands reward consistency over novelty. Supply contracts decide renewal. Margins follow sourcing discipline.
Signal: Indicates Chinese producers are actively adapting product formats to regulatory warnings as supplement channels grow more cautious.

What Drives Biotin Production Costs

Chemical intermediates account for roughly 42% of cost of goods, solvents and reagents about 14%, energy about 16%, and purification, testing, and packaging about 28%. Intermediates and sulfur compounds come from Chinese and Indian chemical makers, and most synthesis takes place in China, with smaller plants in Switzerland, Germany, and India. Batch records protect future sales. Cost control separates leaders from followers.
The clearest recent shock came from Chinese power curbs and energy prices. Provincial power rationing in 2021 cut vitamin output, energy prices surged in 2022, as the IEA reported, and DSM-Firmenich noted in its 2024 annual report that input and energy costs and Chinese vitamin competition affected results. Biotin prices rose by 30% to 80% during the peak of the 2021 disruption. Clear specifications build buyer trust. Small importers feel every input swing.

The competitive disadvantage falls on small non-Chinese suppliers and premix makers without secured supply, which buy on spot terms and cannot fund purification upgrades. Large producers hold intermediates contracts, own integrated sites, and spread compliance cost across volume. Exposure also varies by grade, since feed grade follows energy and intermediates while beauty grades depend on purity and documentation skill.
biotin-ingredients-market-cost-volatility-analysis-1789850985154

Contracting Intermediates and Energy With Index Clauses

Suppliers sign multi-year contracts for intermediates, solvents, and power, and write index clauses into customer contracts with caps and floors. Contracts cut spot purchases by roughly half and clauses cut margin swings by 10% to 20% in volatile years. The main challenge is customer acceptance, so suppliers publish index sources and pair pricing with supply guarantees.

Dual-Site Production and Safety Stock

Suppliers spread output across sites in China, Europe, and India and hold safety stock for key premix customers. Dual sites cut single-curb exposure by about a third and stock covers four to eight weeks of demand. The main challenge is working capital and duplicated compliance, so suppliers target stock at high-margin accounts first. Technical reach compounds over time.

Solvent Recovery and Yield Improvement

Suppliers add solvent recovery, catalyst upgrades, and process analytics that lift yield and cut waste. Recovery cuts solvent cost by 15% to 30% and yield gains cut cost per kilogram by 5% to 10%. The main challenge is capital and skill, so larger suppliers invest first, while smaller firms rely on contract processing. Brands reward consistency over novelty.

Portfolio Architecture for Margin Defence

Margins run from thin returns on feed grade biotin sold in bulk to strong returns on certified beauty and supplement grades sold with documentation. Three tiers separate volume products, certified premium lines, and next-generation formats, and each tier draws on different customer groups, purification lines, and certification paths in a small, concentrated market. Delivery reliability decides supplier rankings. Margins follow sourcing discipline.
The tension between volume and premium is sharp. Feed grade protects plant utilisation and premix relationships but faces price pressure from Chinese capacity, while beauty and supplement grades earn higher margins on smaller volumes and depend on purity, documentation, and brand trust. Suppliers that run only volume struggle to fund upgrades, while suppliers that run only premium lack the volume to cover plants. Buyers review suppliers every season. Batch records protect future sales.

High-value pools concentrate in cosmetic grade biotin sold to hair care and beauty brands and in supplement grades sold to premium brands. They gather where buyers pay for purity, certification, and documentation rather than kilograms. Pharmaceutical and clinical grades add steady value, since buyers need proven, consistent lots for regulated products. Cost control separates leaders from followers. Clear specifications build buyer trust.

Volume / Commodity-Adjacent Tier

Feed grade biotin sold in bags and drums to premix makers and feed producers under annual contracts at thin margins, with price competition from Chinese plants and index-linked pricing. Small importers feel every input swing.
Gross Margin: 22%-32%

Premium / Certified Tier

Supplement, pharmaceutical, and food fortification grades with high purity, particle size control, and audit certificates, sold to brands and clinical nutrition makers that require consistent lots. Technical reach compounds over time. Brands reward consistency over novelty.
Gross Margin: 32%-44%

Sustainability / Regulatory / Next-Generation Tier

Cosmetic grades, low-dose formats, and fermentation-based bio-based biotin with documentation and traceable sourcing, sold to brands that pay premiums for verified performance. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline.
Gross Margin: 38%-52%
biotin-ingredients-market-portfolio-architecture-1789850985461

High-value Sub-segments and Strategic Watch-out

Cosmetic and Personal Care Grade Biotin

Cosmetic and personal care grade biotin combines the fastest growth with strong pricing, since hair care and beauty brands pay for documented, high-purity grades at gross margins of 38% to 52%. Documentation and purity data limit competition, and suppliers with certified plants win. Volume compounds as beauty-from-within demand widens.
Gross Margin: 38%-52%

Dietary Supplement Grade Biotin

Dietary supplement grade biotin delivers strong growth and steady pricing, since supplement brands pay for clean documentation and consistent particle size. Test interference warnings and high-dose limits form the main barrier, and suppliers with low-dose formats win. Repeat supply builds through premium supplement programmes across Asia and North America.
Gross Margin: 34%-46%

Feed Grade Biotin

Feed grade biotin is the volume core, sold to premix and feed makers at thin margins under annual contracts. Value grows about 4.4% a year, and scale, cost position, and delivery reliability decide profit. Suppliers anchor sales on long relationships with premix houses and integrated poultry and swine producers.
Gross Margin: 22%-32%

Food Fortification Grade Biotin

Food fortification grade biotin is the strategic watch-out, since growth of about 6.0% a year sits near the market, national programmes favour other vitamins, and buyers switch on price. Suppliers should manage this line for steady cash and redirect capacity toward higher-value cosmetic and supplement grades.
Gross Margin: 26%-36%

Why Premix Buyers Keep Reordering Biotin

Biotin demand behaves like an annuity attached to approved premix and supplement formulas. Once a buyer qualifies a biotin whose assay, particle size, and stability it trusts, it repeats the order every quarter, and switching means new stability tests, potency checks, and possible label changes. Buyers use last quarter's test results and delivery record to fix renewals, so suppliers with clean records earn steadier volume than sellers reliant
Adoption stickiness differs by end-use vertical. Pharmaceutical and clinical nutrition buyers are the deepest, since biotin is written into registered formulas and changes only when supply or quality fails. Supplement brands follow documentation. Feed premix makers are moderate and switch on cost, while small cosmetic and food brands are shallow and buy through distributors. Buyers review suppliers every season. Batch records protect future sales.

Buyer profiles are shifting between generations. Older premix teams bought biotin on price and long relationships, while younger teams ask for bio-based options, low-dose formats, traceable sourcing, and clean documentation. Retailers add a third group that challenges label claims. Suppliers that publish specifications and offer fast sampling win younger buyers and keep them as beauty supplements grow. Clear specifications build buyer trust.
biotin-ingredients-market-end-use-penetration-index-1789850985671

MMA Verdict on Biotin Strategy

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / PURITY GRADE STRATEGY

Shift Volume Into Cosmetic and Supplement Grades Before Feed Prices Erode Margin

Cosmetic and Personal Care Grade Biotin grows at 8.9% a year, about 1.53 times the overall market rate, and suppliers that add purification lines and certification earn gross margins of 38% to 52% against 22% to 32% for feed grade. Winners will invest $3 million to $10 million per plant and shift 10% of volume into beauty and supplement grades, lifting gross margin by 3 to 6 points. Suppliers with only feed grade will stay exposed to Chinese price competition, and rivals with certified plants will win the fastest-growing accounts.
02 / SUPPLY SECURITY STRATEGY

Hold Second Sources and Safety Stock Before Chinese Curbs Disrupt Premix Programmes

Chinese plants make about 75% of global biotin, and power and emissions curbs can lift prices by 30% to 80% within weeks, so single-source premix makers face shortages and reformulation risk. Suppliers should invest $2 million to $6 million in working capital and dual-site production, hold four to eight weeks of stock for key customers, and offer index-linked pricing with supply guarantees. Those that stay on single sites will lose accounts after one curb, and suppliers with secured supply will hold premium contracts and loyalty across the cycle.
03 / REGULATORY FORMAT STRATEGY

Offer Low-Dose Formats Before Test Interference Warnings Erode Supplement Sales

Regulators warn that high-dose biotin can distort blood test results, and warnings cut high-dose supplement sales by 5% to 10% in cautious channels while retailers and doctors urge caution. Suppliers should invest $0.5 million to $2 million in low-dose blends, labelling guidance, and regulatory summaries, share them with brands, and support retailer requests to protect shelf position. Those that ignore warnings will lose supplement programmes, and suppliers with compliant formats will hold repeat orders and win the cautious channels rivals cannot serve.
04 / FERMENTATION OPTION STRATEGY

Pilot Bio-Based Routes Before Brands Choose Rival Clean-Label Biotin Suppliers

Fermentation could cover 10% to 15% of biotin supply by 2036, and brands will pay premiums of 15% to 30% for bio-based labels, though yields remain below chemical routes. Suppliers should invest $5 million to $15 million in strain work and pilots, test with three brands, measure yield against chemical synthesis, and scale only where premiums cover capital. Those that wait will watch entrants lock in early accounts, and suppliers with proven routes will hold pricing power in the fastest-growing clean-label segments.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Biotin Ingredients Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Biotin Ingredients Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a mid-sized European vitamin premix manufacturer with annual sales near $180 million (client-reported, unverified by MMA), selling poultry, swine, and supplement premixes across Europe and export markets. It bought biotin from two Chinese plants on spot terms, held little safety stock, and had biotin-containing premixes in 40% of sales. Small importers feel every input swing.
STRATEGIC CHALLENGE
Biotin prices had spiked during a Chinese power curb, customers were asking for supply guarantees, and one lot had shown a potency shortfall. Management needed to decide whether to sign long-term contracts, add a European second source, or hold more stock, with limited working capital and a contract renewal date. Technical reach compounds over time.
MMA APPROACH
MMA analysed purchase, price, and complaint data across 14 premix products, interviewed nine procurement, quality, and supplier experts and five customers, and ran a supplier survey on lead time, potency, and price across three countries. It modelled cost by sourcing scenario, tested curb and price spike cases, and ranked options by payback and execution risk.
KEY FINDINGS
  1. A European second source would cost about 12% more per kilogram but cut curb exposure by about half (client-reported, unverified by MMA). Brands reward consistency over novelty.
  2. Six weeks of safety stock would cost about $1.8 million in working capital and protect 40% of sales. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
  3. Index-linked customer clauses could recover about 60% of price spikes within one quarter. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales.
  4. Incoming assay testing and supplier audits would remove potency shortfalls and cut rejected lots by about a third. Cost control separates leaders from followers.
CLIENT PROFILE
The client is a mid-sized European vitamin premix manufacturer with annual sales near $180 million (client-reported, unverified by MMA), selling poultry, swine, and supplement premixes across Europe and export markets. It bought biotin from two Chinese plants on spot terms, held little safety stock, and had biotin-containing premixes in 40% of sales. Small importers feel every input swing.
STRATEGIC CHALLENGE
Biotin prices had spiked during a Chinese power curb, customers were asking for supply guarantees, and one lot had shown a potency shortfall. Management needed to decide whether to sign long-term contracts, add a European second source, or hold more stock, with limited working capital and a contract renewal date. Technical reach compounds over time.
MMA APPROACH
MMA analysed purchase, price, and complaint data across 14 premix products, interviewed nine procurement, quality, and supplier experts and five customers, and ran a supplier survey on lead time, potency, and price across three countries. It modelled cost by sourcing scenario, tested curb and price spike cases, and ranked options by payback and execution risk.
KEY FINDINGS
  1. A European second source would cost about 12% more per kilogram but cut curb exposure by about half (client-reported, unverified by MMA). Brands reward consistency over novelty.
  2. Six weeks of safety stock would cost about $1.8 million in working capital and protect 40% of sales. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
  3. Index-linked customer clauses could recover about 60% of price spikes within one quarter. Margins follow sourcing discipline. Buyers review suppliers every season. Batch records protect future sales.
  4. Incoming assay testing and supplier audits would remove potency shortfalls and cut rejected lots by about a third. Cost control separates leaders from followers.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1-6): Qualify a European second source, add incoming assay testing, and build four weeks of safety stock. Clear specifications build buyer trust. Phase 2: Phase 2 (Months 7-24): Sign index-linked customer clauses and multi-year supply contracts with both sources. Small importers feel every input swing. Phase 3: Phase 3 (Months 25-42): Extend stock to six weeks, audit suppliers yearly, and review sourcing cost and risk quarterly. Technical reach compounds over time.
OUTCOME
Within 42 months, dual-source supply covered 70% of biotin volume, potency rejects fell to near zero, and the price spike that once cost the client heavily was largely passed through (client-reported, unverified by MMA). The client kept all major contracts, held stockouts below 2%, and improved gross margin by 2 points.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Biotin Ingredients Market?

The global biotin ingredients market was valued at $0.90 billion in 2025 on a supplier-value basis. Growth is supported by livestock output and beauty supplements, offset by test interference warnings and Chinese supply risk.

How large will the Biotin Ingredients Market be by 2036?

The market is projected to reach $1.67 billion by 2036, up from $0.95 billion in 2026. The increase of $0.72 billion reflects cosmetic and supplement grades and steady feed demand.

What is the CAGR for the Biotin Ingredients Market 2026 to 2036?

The market is forecast to grow at a 5.8% CAGR from 2026 to 2036, supported by feed and beauty demand. The bull case reaches 7.1% and the bear case 4.5%, depending on Chinese capacity, regulation, and livestock margins.

Which segment is growing fastest?

Cosmetic and Personal Care Grade Biotin is the fastest-growing segment at 8.9% CAGR, roughly 1.53 times the overall market rate. Dietary Supplement Grade Biotin follows at 7.4% CAGR each year.

Who are the major companies in the Biotin Ingredients Market?

Major companies include DSM-Firmenich, Zhejiang Medicine, Zhejiang NHU, Kingdomway Group, and Fermenta Biotech. BASF, Adisseo, Lonza, Kemin, and Kerry Group also hold meaningful positions in vitamins and premixes.

Which country is growing fastest?

India is growing fastest at about 8.2% CAGR, because supplement use and poultry output are expanding quickly. Vietnam and Indonesia follow as premix and beauty demand widens.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Primary Market Dimension

  • Feed Grade Biotin
  • Dietary Supplement Grade Biotin
  • Pharmaceutical and Clinical Grade Biotin
  • Cosmetic and Personal Care Grade Biotin
  • Food Fortification Grade Biotin

By End-Use Industry

  • Animal Nutrition and Feed
  • Dietary Supplements
  • Pharmaceuticals and Clinical Nutrition
  • Cosmetics and Personal Care
  • Food and Beverage Fortification

By Commercial Dimension

  • Direct Supply Contracts
  • Ingredient Distributors
  • Premix Manufacturer Programmes
  • Spot Market Sales
  • Private Label Supply

By Region

  • East Asia
  • North America
  • Western Europe
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The market covers global sales of biotin as an ingredient, valued at supplier level, including feed grade biotin, dietary supplement grade biotin, pharmaceutical and clinical grade biotin, cosmetic and personal care grade biotin, and food fortification grade biotin, sold in crystalline, granulated, and premix forms. The scope excludes finished supplements, finished cosmetics, multi-vitamin premixes sold as blended products, and other B vitamins.
Quantitative Units
USD billions (supplier value); metric tonnes for volume references
Segmentation Dimensions
By End-Use Grade; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
East Asia, North America, Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
China, Japan, South Korea, India, Vietnam, Indonesia, Netherlands, Germany, France, Switzerland, United States, Canada, Brazil, Mexico, United Arab Emirates, Poland, and additional markets relevant to this sector
Key Companies Profiled
DSM-Firmenich, Zhejiang Medicine, Zhejiang NHU, Kingdomway Group, Fermenta Biotech, BASF, Adisseo, Lonza, Kemin, Kerry Group, Prinova Group, Barentz, Brenntag, Univar Solutions, Azelis, CSPC Pharmaceutical, Vertellus, Jubilant Ingredients, Balchem, Nutreco
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-CHM-621
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Biotin Ingredients Market Report (2026 to 2036).

The full report delivers a detailed assessment of the global biotin ingredients market through 2036, covering end-use grade, industry, and regional forecasts, competitive benchmarking of leading suppliers, and input cost analysis. It combines MMA primary research, including a six-country survey of 3,800 respondents and 47 expert interviews, with public statistical and company data. Analysts also model Chinese curb scenarios, regulatory timelines, and fermentation adoption. Clients receive grade margin ranges, sourcing maps, and a case study on sourcing strategy. Customer programme and supply contract frameworks are also included for planning.
Ten-year grade and end-use demand forecasts
Intermediates, energy, and freight cost tracking
Competitive benchmarking of top twenty suppliers
Chinese output curb and FDA warning tracker
Regional supply chain comparative analysis included
Quarterly primary survey data update access

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts